In Vitro susceptibility of Gram-positive cocci isolated from skin and respiratory tract to azithromycin and twelve other antimicrobial agents

This study was conducted to evaluate the activity of azithromycin in comparison to 12 other antibacterial agents against recent isolates obtained consecutively from patients with respiratory tract or skin infections, from January to July, 2000. A total of 717 Gram-positive cocci were analyzed in thi...

Full description

Bibliographic Details
Main Authors: Caio M. F. Mendes, Sumiko I. Sinto, Carmen Paz Oplustil
Format: Article
Language:English
Published: Elsevier
Series:Brazilian Journal of Infectious Diseases
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702001000500005&lng=en&tlng=en
_version_ 1828858597512052736
author Caio M. F. Mendes
Sumiko I. Sinto
Carmen Paz Oplustil
author_facet Caio M. F. Mendes
Sumiko I. Sinto
Carmen Paz Oplustil
author_sort Caio M. F. Mendes
collection DOAJ
description This study was conducted to evaluate the activity of azithromycin in comparison to 12 other antibacterial agents against recent isolates obtained consecutively from patients with respiratory tract or skin infections, from January to July, 2000. A total of 717 Gram-positive cocci were analyzed in this study and the following species were studied: Staphylococcus aureus (n=576), beta-hemolytic streptococci ( n=115), and Streptococcus pneumoniae (n=26). Susceptibility testing was carried out by the disk diffusion method and interpreted according to NCCLS breakpoints. The activity of azithromycin was compared to erythromycin, clindamycin, chloramphenicol, ciprofloxacin, ofloxacin, oxacillin, penicillin, ceftriaxone, tetracycline, trimethoprim/sulfamethoxazole, teicoplanin, and vancomycin. Of the 26 S. pneumoniae isolates recovered from the respiratory tract, 5 (19.2%) were intermediate resistant to penicillin. All of these strains were susceptible to chloramphenicol, ofloxacin, and vancomycin, and 24 (92%) were also susceptible to azithromycin, clindamycin, and erythromycin. Among the 67 beta-hemolytic streptococci strains isolated from the respiratory tract, 66 (99%) were susceptible to azithromycin, erythromycin, clindamycin, and ofloxacin. All 48 beta-hemolytic streptococci strains isolated from skin were susceptible to azithromycin and clindamycin, 47 (98%) were susceptible to erythromycin, and 46 (96%) were susceptible to ofloxacin. Of the 576 strains of S. aureus, 253 (43.9%) were isolated from the respiratory tract and 323 (56.1%) from skin. Among S. aureus isolates from the respiratory tract and skin, 46 (18%) and 78 (24%), respectively were resistant to oxacillin. Isolates from the respiratory tract and skin showed the same percentage of resistance (36%) to azithromycin. These in vitro results suggest that azithromycin can be a therapeutic option for treatment of infections caused by these bacteria since the newer macrolides have several distinct advantages over erytromycin including improved oral bioavailability, longer half-life allowing once or twice daily administration, higher tissue concentrations and less gastrointestinal adverse effects.
first_indexed 2024-12-13T01:59:45Z
format Article
id doaj.art-4843f32e09504d9ba8286f33bba9daae
institution Directory Open Access Journal
issn 1678-4391
language English
last_indexed 2024-12-13T01:59:45Z
publisher Elsevier
record_format Article
series Brazilian Journal of Infectious Diseases
spelling doaj.art-4843f32e09504d9ba8286f33bba9daae2022-12-22T00:03:17ZengElsevierBrazilian Journal of Infectious Diseases1678-43915526927610.1590/S1413-86702001000500005S1413-86702001000500005In Vitro susceptibility of Gram-positive cocci isolated from skin and respiratory tract to azithromycin and twelve other antimicrobial agentsCaio M. F. Mendes0Sumiko I. Sinto1Carmen Paz Oplustil2Fleury Medicina e SaúdeFleury Medicina e SaúdeFleury Medicina e SaúdeThis study was conducted to evaluate the activity of azithromycin in comparison to 12 other antibacterial agents against recent isolates obtained consecutively from patients with respiratory tract or skin infections, from January to July, 2000. A total of 717 Gram-positive cocci were analyzed in this study and the following species were studied: Staphylococcus aureus (n=576), beta-hemolytic streptococci ( n=115), and Streptococcus pneumoniae (n=26). Susceptibility testing was carried out by the disk diffusion method and interpreted according to NCCLS breakpoints. The activity of azithromycin was compared to erythromycin, clindamycin, chloramphenicol, ciprofloxacin, ofloxacin, oxacillin, penicillin, ceftriaxone, tetracycline, trimethoprim/sulfamethoxazole, teicoplanin, and vancomycin. Of the 26 S. pneumoniae isolates recovered from the respiratory tract, 5 (19.2%) were intermediate resistant to penicillin. All of these strains were susceptible to chloramphenicol, ofloxacin, and vancomycin, and 24 (92%) were also susceptible to azithromycin, clindamycin, and erythromycin. Among the 67 beta-hemolytic streptococci strains isolated from the respiratory tract, 66 (99%) were susceptible to azithromycin, erythromycin, clindamycin, and ofloxacin. All 48 beta-hemolytic streptococci strains isolated from skin were susceptible to azithromycin and clindamycin, 47 (98%) were susceptible to erythromycin, and 46 (96%) were susceptible to ofloxacin. Of the 576 strains of S. aureus, 253 (43.9%) were isolated from the respiratory tract and 323 (56.1%) from skin. Among S. aureus isolates from the respiratory tract and skin, 46 (18%) and 78 (24%), respectively were resistant to oxacillin. Isolates from the respiratory tract and skin showed the same percentage of resistance (36%) to azithromycin. These in vitro results suggest that azithromycin can be a therapeutic option for treatment of infections caused by these bacteria since the newer macrolides have several distinct advantages over erytromycin including improved oral bioavailability, longer half-life allowing once or twice daily administration, higher tissue concentrations and less gastrointestinal adverse effects.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702001000500005&lng=en&tlng=enGram-positive cocciazithromycinrespiratory tract infectionskin infectionmacrolide
spellingShingle Caio M. F. Mendes
Sumiko I. Sinto
Carmen Paz Oplustil
In Vitro susceptibility of Gram-positive cocci isolated from skin and respiratory tract to azithromycin and twelve other antimicrobial agents
Brazilian Journal of Infectious Diseases
Gram-positive cocci
azithromycin
respiratory tract infection
skin infection
macrolide
title In Vitro susceptibility of Gram-positive cocci isolated from skin and respiratory tract to azithromycin and twelve other antimicrobial agents
title_full In Vitro susceptibility of Gram-positive cocci isolated from skin and respiratory tract to azithromycin and twelve other antimicrobial agents
title_fullStr In Vitro susceptibility of Gram-positive cocci isolated from skin and respiratory tract to azithromycin and twelve other antimicrobial agents
title_full_unstemmed In Vitro susceptibility of Gram-positive cocci isolated from skin and respiratory tract to azithromycin and twelve other antimicrobial agents
title_short In Vitro susceptibility of Gram-positive cocci isolated from skin and respiratory tract to azithromycin and twelve other antimicrobial agents
title_sort in vitro susceptibility of gram positive cocci isolated from skin and respiratory tract to azithromycin and twelve other antimicrobial agents
topic Gram-positive cocci
azithromycin
respiratory tract infection
skin infection
macrolide
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702001000500005&lng=en&tlng=en
work_keys_str_mv AT caiomfmendes invitrosusceptibilityofgrampositivecocciisolatedfromskinandrespiratorytracttoazithromycinandtwelveotherantimicrobialagents
AT sumikoisinto invitrosusceptibilityofgrampositivecocciisolatedfromskinandrespiratorytracttoazithromycinandtwelveotherantimicrobialagents
AT carmenpazoplustil invitrosusceptibilityofgrampositivecocciisolatedfromskinandrespiratorytracttoazithromycinandtwelveotherantimicrobialagents